Cite
HARVARD Citation
Campone, M. et al. (2021). A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial). European journal of cancer. pp. 169-180. [Online].